African swine fever and classical swine fever are contagious viral diseases which affect only pigs. These diseases are caused by two unrelated viruses, however they are difficult to distinguish from one another. ‘Hog cholera’ is the other name of classical swine fever. The severity of the disease depends on the immune status of the herd, strain of the virus, and the age of the pig. African swine fever is a contagious and deadly viral disease which affects domestic and feral swine in all age groups. The Clinical symptoms of ASF and CSF are loss of appetite, depression, blue blotching of the ears, nose and limbs. Pigs can be carriers of both the diseases for a long period of time, so their movement must be restricted during the outbreak.
The global swine fever vaccine market is forecast to be valued at US$ 2,724.5 Mn in 2022 over the forecast period.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5195
Impact of COVID-19:
The COVID-19 outbreak was reported in December 2019, and it was transmitted to more than 100 nations around the world and the WHO declared coronavirus as a public health emergency in January 2020.
The pandemic had a negative impact on the production, supply and development of medicines and this had a huge impact on the growth of pharmaceutical business around the world.
The lockdown resulted in shutting down of various industrial establishments, other than essential commodities. It also disrupted the supply chain in the pharmaceutical sector. COVID-19 directly affected the economy by impacting the production and demand and it also disrupted the distribution channels. The pandemic also caused a financial impact in many firms and the financial markets.
Manufacturing activities and supply chains in China, the U.S. and India are disrupted owing to strict lockdowns and many other nations like the UAE, Saudi Arabia, Egypt and many other nations are facing challenges regarding transportation of vaccines and drugs. These reasons are estimated to hamper growth of the global swine fever vaccine market.
Rising outbreaks of swine fever are estimated to fuel growth of the global swine fever vaccine market over the forecast period. For instance, a senior official from the Veterinary and Animal Husbandry Department mentioned that259 pigs have died due to African swine fever in Meghalaya’s Ri-Bhoi district in India, until May9, 2022. The Veterinary department reported the first outbreak on April 13, 2022, after this many instructions were issued under the Prevention and Control of Infectious and Contagious Diseases in Animals Act, 2009, which banned the slaughter, supplies and movement of pigs in the Umshorshor village and within 10 km of its vicinity, in Meghalaya, India.
Rising research and development activities for developing vaccine for swine fewer by key players, non-government and government organizations are estimated to augment growth of the global swine fever vaccine market during the forecast period. For instance, NAVET-ASFVAC, a vaccine for African swine fever has been developed in Vietnam along with the U.S. for pigs in June 2022. Vietnamese researchers and the U.S. researchers were working on the NAVET-ASFVAC jab from 2020.
Strict regulatory approvals are estimated to hamper growth of the global swine fever vaccine market over the forecast period. The U.S. Food and Drug Administration, the EPA (Environmental Protection Agency) and the United States Department of Agriculture are federal agencies that are involved in approval of animal medicines. Animal medicines are researched and tested vigorously for purity, efficacy and safety while they are undergoing approval. This process can take up to five to seven years and costs millions of dollars.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5195
- African Swine Fever
- Classical Swine Fever
By Vaccine Type:
- Chimeric (Live-attenuated or inactivated)
- Subunit or vector system based
- Replicon vaccine
By Distribution Channel:
- North America
- Latin America
- Asia Pacific
- Middle East
Key players active in the global swine fever vaccine market are Boehringer Ingelheim International GmbH, Bioveta, a.s., Merck & Co., Inc., EC21 Inc., Ceva, Zoetis Services LLC, Komipharm, and Indian Immunologicals Ltd.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Swine Fever Vaccine Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Swine Fever Vaccine Industry Impact
Chapter 2 Global Swine Fever Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Swine Fever Vaccine (Volume and Value) by Type
2.3 Global Swine Fever Vaccine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Swine Fever Vaccine Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Swine Fever Vaccine Market Analysis
Chapter 6 East Asia Swine Fever Vaccine Market Analysis
Chapter 7 Europe Swine Fever Vaccine Market Analysis
Chapter 8 South Asia Swine Fever Vaccine Market Analysis
Chapter 9 Southeast Asia Swine Fever Vaccine Market Analysis
Chapter 10 Middle East Swine Fever Vaccine Market Analysis
Chapter 11 Africa Swine Fever Vaccine Market Analysis
Chapter 12 Oceania Swine Fever Vaccine Market Analysis
Chapter 13 South America Swine Fever Vaccine Market Analysis
Chapter 14 Company Profiles and Key Figures in Swine Fever Vaccine Business
Chapter 15 Global Swine Fever Vaccine Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5195
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027